Crinetics Pharmaceuticals Inc buy JPMorgan Chase & Co.
Start price
24.09.25
/
50%
€30.40
Target price
24.09.26
€44.06
Performance (%)
41.45%
Price
12.12.25
€43.00
Summary
This prediction is currently active. With a performance of 41.45% the BUY prediction by JPMorgan_Chase___Co_ is a big success. This prediction currently runs until 24.09.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Crinetics Pharmaceuticals Inc | 5.392% | 5.392% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target lowered by analysts at JPMorgan Chase & Co. from $53.00 to $52.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€44.60
09.07.24
09.07.24
€49.94
09.07.25
09.07.25
-39.01%
10.07.25
10.07.25
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€27.40
20.11.23
20.11.23
€32.04
20.11.24
20.11.24
100.73%
21.11.24
21.11.24